article_snippet.sent: A new HIV treatment pioneered using an antibody to attack virus could lead to a new vaccine to prevent the infection.
article_snippet.sent: The scientists behind the discovery believe The scientists behind the discovery findings offer new strategies for fighting or even preventing HIV infection.
article_snippet.sent: New antibody  was designed by researchers to block the key viral protein receptor that is needed to infect human blood cells.
article_snippet.sent: Scientists at the Rockefeller University in New York believe a new antibody therapy could pave the way for an HIV vaccine after clinical trials revealed A new HIV treatment pioneered using an antibody to attack the virus resulted in a 300-fold decrease in the amount of HIV, pictured, in sufferers' blood .
article_snippet.sent: The team of scientists at the Rockefeller University in New York now believe that using synthetic antibodies that attached to the surface of proteins on the outer membrane of the HIV virus, could offer an alternative treatment to the anti-retroviral drugs currently used. using synthetic antibodies that attached to the surface of proteins on the outer membrane of the HIV virus, could offer an alternative treatment to the anti-retroviral drugs currently used hope the breakthrough will result in new therapeutic vaccines.
article_snippet.sent: HIV antibodies previously tested in humans had shown disappointing results, but the antibody tested at the Rockefeller University belongs to a new generation of broadly neutralising antibodies that potently fight a wide range of HIV strains.
article_snippet.sent: What's special about these antibodies is that these antibodies have activity against over 80 per cent of HIV strains and these antibodies are extremely potent.'
article_snippet.sent: Previous research showed the new antibody therapy was effective against 195 of 237 HIV strains.
article_snippet.sent: However, by isolating and cloning these antibodies, researchers are able to harness these antibodies as therapeutic agents to use against HIV infections that have had less time to evolve.
article_snippet.sent: As part of a groundbreaking study published, uninfected and HIV-infected people were given a single dose of the new antibody therapy intravenously, and monitored for 56 days.
article_snippet.sent: a groundbreaking study published marks the first time the new generation of HIV antibodies has been tested in humans.
article_snippet.sent: Dr Marina Caskey, co-first author of a groundbreaking study published, said: 'What's special about HIV antibodies is that HIV antibodies have activity against over 80 per cent of HIV strains and HIV antibodies are extremely potent.'
article_snippet.sent: Besides the possibility of treatment, a groundbreaking study published also raises hopes for an HIV vaccine.
highlights_snippet.sent: New antibody blocks protein receptor needed to infect human cells .
  
highlights_snippet.sent: Scientists believe breakthrough could result in new vaccines against virus .